Literature DB >> 2113816

Levonorgestrel-releasing intrauterine device.

T Luukkainen1, P Lähteenmäki, J Toivonen.   

Abstract

An intrauterine contraceptive device releasing 20 micrograms levonorgestrel daily has been studied for 15 years. The international clinical experience covers over 8000 woman years. Main characteristics of the levonorgestrel-releasing intrauterine device are its great effectiveness in preventing unplanned pregnancies and a reduction in menstrual bleeding and pain as well as a low infection rate.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2113816     DOI： 10.3109/07853899009147248

Source DB:  PubMed          Journal:  Ann Med        ISSN： 0785-3890            Impact factor:   4.709


  22 in total

Review 1.  Recent developments in hormonal contraception.

Authors:  Eleanor A Drey; Philip D Darney
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

2.  Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy.

Authors:  P Lähteenmäki; M Haukkamaa; J Puolakka; U Riikonen; S Sainio; J Suvisaari; C G Nilsson
Journal:  BMJ       Date:  1998-04-11

Review 3.  A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Authors:  F Sturridge; J Guillebaud
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

4.  Endometriosis causing lower extremity deep vein thrombosis - case report and review of the literature.

Authors:  Rajinder P Sharma; Fadi Delly; Horia Marin; Scott Sturza
Journal:  Int J Angiol       Date:  2009

5.  Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report.

Authors:  C Kailasam; V Akande; U D Gordon
Journal:  J Assist Reprod Genet       Date:  2005-03       Impact factor: 3.412

Review 6.  Update on hormonal contraception and bone density.

Authors:  Michelle M Isley; Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

7.  Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment.

Authors:  Gabriella Macchia; Francesco Deodato; Savino Cilla; Francesco Legge; Vito Carone; Vito Chiantera; Vincenzo Valentini; Alessio Giuseppe Morganti; Gabriella Ferrandina
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

8.  Management of dysfunctional uterine bleeding.

Authors:  C M Farquhar
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

9.  Impact of patient information booklet on treatment decision--a randomized trial among women with heavy menstruation.

Authors:  Sirkku Vuorma; Pekka Rissanen; Anna-Mari Aalto; Ritva Hurskainen; Erkki Kujansuu; Juha Teperi
Journal:  Health Expect       Date:  2003-12       Impact factor: 3.377

10.  Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system.

Authors:  Chandra Kailasam; David Cahill
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.